Search Results for "Hepatomegaly In Dengue Haemorrhagic Fever"

18:23 EDT 29th March 2015 | BioPortfolio

Matching Channels

Dengue Hemorrhagic Fever

Dengue Virus Vaccines

It is estimated that about 100 million cases of infection by Dengue virus occur each year and that nearly half the world’s population is at risk of Dengue virus infection. At present, no vacci...

Dengue

Fever

Q Fever

Matching News

Making Dengue the Next Vaccine-Preventable Disease

Each year, there are approximately 50 million Dengue infections and an estimated 500,000 individuals are hospitalized with Dengue haemorrhagic fever. There have been attempts to ... The post Making De...

Trial results raise hope for dengue fever vaccine

A tetravalent dengue vaccine has shown efficacy against dengue fever and severe dengue fever and led to fewer hospitalisations in a randomised, blinded, placebo controlled trial.The efficacy trial,......

A very personal perspective on Dengue fever

Leah Katzelnick was all set for a career as an anthropologist until she contracted dengue fever. She was in hospital for a week with severe symptoms. It changed her life. She is now working on a new p...

New approach holds promise for dengue fever

Monash University and 60P Australia Pty Ltd (60P), a subsidiary of 60° Pharmaceuticals LLC, have announced today an exclusive partnering deal, with 60P obtaining rights to develop the drug Fenretinid...

Dengue fever, malaria in the Himalayas

Research by Nepalese and German scientists analyzes the current situation of malaria and Dengue fever in the Himalayan country of Nepal, and highlights how they profit from climate change and globaliz...

Military Researchers Weigh Infecting Volunteers With Dengue Fever

U.S. military scientists are considering resurrecting a research program that would infect healthy people with dengue fever, the potentially deadly mosquito-borne disease that has no known drug treatm...

Brazil releases over 10,000 dengue-blocking mosquitoes

Researchers in Brazil have released thousands of mosquitoes infected with dengue-blocking bacteria as part of 'Eliminate the dengue: Challenge Brazil' project to fight against dengue fever in a natura...

Sumitomo Chemical develops SumiLarv 2 MR to prevent dengue fever

Sumitomo Chemical is pleased to announce that it has developed SumiLarv 2 MR, a novel, long - lasting larvicide formulation that is effective in preventing dengue fever.

Matching PubMed Articles

Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic fever.

Suppresors of cytokine signalling (SOCS) proteins regulate cytokine responses and control immune balance. The objective of our study was to determine whether the expression of SOCS1 and its potential ...

Geospatial analysis applied to epidemiological studies of dengue: a systematic review.

A systematic review of the geospatial analysis methods used in the dengue fever studies published between January 2001 and March 2011 was undertaken. In accordance with specific selection criteria thi...

Dengue fever: Natural management.

Dengue fever is caused by the mosquito-borne dengue virus (DENV) serotypes 1-4, and is the most common arboviral infection of humans in subtropical and tropical regions of the world. Dengue virus infe...

Cost-utility analysis of an adjunctive recombinant activated factor VIIa for on-demand treatment of bleeding episodes in dengue haemorrhagic fever.

The present study aimed to assess the cost-utility analysis of using an adjunctive recombinant activated factor VIIa (rFVIIa) in children for controlling life-threatening bleeding in dengue haemorrhag...

Bilateral acute visual loss from Rathke's cleft cyst apoplexy in a patient with dengue fever.

Hemorrhagic complications of optic pathway diseases are extremely rare causes of acute visual loss associated with dengue fever. In this paper we report a patient presenting with dengue fever and bila...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement